Patent · US Active

Insertable variable fragments of antibodies and modified A1-A2 domains of NKG2D ligands

US11453713B2 · kind B2 · utility

0Cited by

2References

11Claims

0Family size

Assignee

XYPHOS BIOSCIENCES INC. · US

Inventors

Kyle Landgraf · Alameda, US
Daniel Steiger · San Francisco, US
Steven R. Williams · Colorado Springs, US
David W. Martin · San Francisco, US

Key dates

Filing date	Dec 4, 2015
Grant date	Sep 27, 2022
Priority date	—
Expiry date	Oct 11, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/74
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This application relates generally to the production of polypeptides having specific antigen-binding properties of Fv domains, for example, insertable variable fragments of antibodies, and modified α1-α2 domains of NKG2D ligands.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.